Difference between revisions of "Team:Aachen/Workflow"

 
(10 intermediate revisions by the same user not shown)
Line 4: Line 4:
 
<body>
 
<body>
 
<style scoped>
 
<style scoped>
 +
.SafText strong{
 +
    font-size: 24px;
 +
}
 
.subboxb{
 
.subboxb{
 
width: 100%;
 
width: 100%;
Line 32: Line 35:
 
}
 
}
 
.SafText{
 
.SafText{
font-size:18px;
+
font-size:24px;
 
text-align:justify;
 
text-align:justify;
 
}
 
}
Line 53: Line 56:
 
How are we doing genomic modifications? Which methods are we using from the beginning to the  end of the complete process? This flowchart gives you a detailed overview. Together with the given protocols you can repeat it down to every little pipetting- step we made!
 
How are we doing genomic modifications? Which methods are we using from the beginning to the  end of the complete process? This flowchart gives you a detailed overview. Together with the given protocols you can repeat it down to every little pipetting- step we made!
 
</p>
 
</p>
<p class="SafText" style="font-size:150%;color:#003559;text-align:center;">
+
<p class="SafText" style="font-size:200%;color:#003559;text-align:center;">
 
<strong>Planning</strong>
 
<strong>Planning</strong>
 
</p>
 
</p>
Line 67: Line 70:
 
</div>
 
</div>
 
</div>
 
</div>
<div class="row">
+
<div class="row">
<div class="col-xs-12">
+
                <div class="col-sm-5"></div>
<img src="https://static.igem.org/mediawiki/2017/c/cd/T--Aachen--Workflow_Arrow.png" style="width:95%;margin-left:2.5%;width:20%;margin-left:40%;"></img>
+
<div class="col-sm-2">
 +
<img class="img-responsive" src="https://static.igem.org/mediawiki/2017/c/cd/T--Aachen--Workflow_Arrow.png" />
 
</div>
 
</div>
 +
                <div class="col-sm-5"></div>
 +
        </div>
 +
        <div class="row">
 
<div class="col-md-3"></div>
 
<div class="col-md-3"></div>
 
<div class="col-md-6">
 
<div class="col-md-6">
<p class="SafText" style="font-size:150%;color:#003559;text-align:center;margin-top:10px;">
+
<p class="SafText" style="font-size:200%;color:#003559;text-align:center;margin-top:10px;">
 
<strong>PCR</strong>
 
<strong>PCR</strong>
 
</p>
 
</p>
Line 86: Line 93:
 
</div>
 
</div>
 
</div>
 
</div>
<div class="row">
+
<div class="row">
<div class="col-xs-12">
+
                <div class="col-sm-5"></div>
<img src="https://static.igem.org/mediawiki/2017/c/cd/T--Aachen--Workflow_Arrow.png" style="width:95%;margin-left:2.5%;width:20%;margin-left:40%;"></img>
+
<div class="col-sm-2">
 +
<img class="img-responsive" src="https://static.igem.org/mediawiki/2017/c/cd/T--Aachen--Workflow_Arrow.png" />
 
</div>
 
</div>
 +
                <div class="col-sm-5"></div>
 +
        </div>
 +
        <div class="row">
 
<div class="col-md-2"></div>
 
<div class="col-md-2"></div>
 
<div class="col-md-8">
 
<div class="col-md-8">
<p class="SafText" style="font-size:150%;color:#003559;text-align:center;margin-top:10px;">
+
<p class="SafText" style="font-size:200%;color:#003559;text-align:center;margin-top:10px;">
 
<strong>Transformation and Homologous Recombination</strong>
 
<strong>Transformation and Homologous Recombination</strong>
 
</p>
 
</p>
Line 106: Line 117:
 
<div class="row" style="margin-top:30px;">
 
<div class="row" style="margin-top:30px;">
 
<div class="col-xs-12">
 
<div class="col-xs-12">
<img src="https://static.igem.org/mediawiki/2017/6/6b/T--Aachen--Workflow_Transformation_Integration_3_4.png" style="width:100%;"></img>
+
<img src="https://static.igem.org/mediawiki/2017/6/6b/T--Aachen--Workflow_Transformation_Integration_3_4.png" style="width:100%;" />
 
</div>
 
</div>
 
</div>
 
</div>
Line 119: Line 130:
 
</p>
 
</p>
 
</div>
 
</div>
<div class="col-md-3"><img src="https://static.igem.org/mediawiki/2017/c/cd/T--Aachen--Workflow_Arrow.png" style="width:70%;"></img></div>
+
<div class="col-md-3"><img src="https://static.igem.org/mediawiki/2017/4/4c/T--Aachen--Workflow_Arrow_2.png" style="width:70%;"></img></div>
 
</div>
 
</div>
 
<div class="row" style="margin-top:30px;">
 
<div class="row" style="margin-top:30px;">
Line 126: Line 137:
 
</div>
 
</div>
 
</div>
 
</div>
<div class="row">
+
<div class="row">
<div class="col-xs-12">
+
                <div class="col-sm-5"></div>
<img src="https://static.igem.org/mediawiki/2017/6/6b/T--Aachen--Workflow_Transformation_Integration_3_4.png" style="width:95%;margin-left:2.5%;width:20%;margin-left:40%;"></img>
+
<div class="col-sm-2">
 +
<img class="img-responsive" src="https://static.igem.org/mediawiki/2017/c/cd/T--Aachen--Workflow_Arrow.png" />
 
</div>
 
</div>
 +
                <div class="col-sm-5"></div>
 +
        </div>
 +
        <div class="row">
 
<div class="col-md-3"></div>
 
<div class="col-md-3"></div>
 
<div class="col-md-6">
 
<div class="col-md-6">
<p class="SafText" style="font-size:150%;color:#003559;text-align:center;margin-top:10px;">
+
<p class="SafText" style="font-size:200%;color:#003559;text-align:center;margin-top:10px;">
 
<strong>Cre- loxP Treatment</strong>
 
<strong>Cre- loxP Treatment</strong>
 
</p>
 
</p>

Latest revision as of 20:14, 31 October 2017

iGEM Team Aachen 2017

Workflow

How are we doing genomic modifications? Which methods are we using from the beginning to the end of the complete process? This flowchart gives you a detailed overview. Together with the given protocols you can repeat it down to every little pipetting- step we made!

Planning

Planning of the whole cassette and its fragments in geneious, designing primers with overhangs (which ensure the later assembly of the composite cassette) for it and synthesize them via IDT.

PCR

Produce the fragments via PCR, so the overhangs generate the homologous parts of each of the fragments.

Transformation and Homologous Recombination

(A) Transformation of the fragments into the yeast cells. (B) The homologous parts of the fragments ensure that the fragments are assembled in the right order after transformation inside the cell. (C) Integration of the composite cassette into the part of one chromosome, encoded by the recombination sites at the 5'- and 3'- ends of the whole cassette.

Verification

After growth on the auxotrophy- plates verification through verification- PCR. Because the lengths of the cassettes were often quite long for one PCR, often multiple primer pairs were used. When the PCR has been successful and the gel showed the awaited length, sequencing of the introduced gene is given in order.

Cre- loxP Treatment

After complete verification, the marker gene between the loxp- sites is removed through the cre protein, for further transformation and for avoidance of antibiotic resistant cells.